Showing Value in Newborn Screening: Challenges in Quantifying the Effectiveness and Cost-Effectiveness of Early Detection of Phenylketonuria and Cystic Fibrosis.
about
Onset of persistent pseudomonas aeruginosa infection in children with cystic fibrosis with interval censored data.The Use of Economic Evaluation to Inform Newborn Screening Policy Decisions: The Washington State Experience.The Sweat Metabolome of Screen-Positive Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.Amblyopia screening: a new screening protocol implemented in Croatia.Cost and Cost-Effectiveness Assessments of Newborn Screening for Critical Congenital Heart Disease Using Pulse Oximetry: A Review.What Contribution Did Economic Evidence Make to the Adoption of Universal Newborn Hearing Screening Policies in the United States?
P2860
Showing Value in Newborn Screening: Challenges in Quantifying the Effectiveness and Cost-Effectiveness of Early Detection of Phenylketonuria and Cystic Fibrosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Showing Value in Newborn Scree ...... ketonuria and Cystic Fibrosis.
@ast
Showing Value in Newborn Scree ...... ketonuria and Cystic Fibrosis.
@en
type
label
Showing Value in Newborn Scree ...... ketonuria and Cystic Fibrosis.
@ast
Showing Value in Newborn Scree ...... ketonuria and Cystic Fibrosis.
@en
prefLabel
Showing Value in Newborn Scree ...... ketonuria and Cystic Fibrosis.
@ast
Showing Value in Newborn Scree ...... ketonuria and Cystic Fibrosis.
@en
P2860
P1433
P1476
Showing Value in Newborn Scree ...... ketonuria and Cystic Fibrosis.
@en
P2093
Scott D Grosse
P2860
P304
P356
10.3390/HEALTHCARE3041133
P577
2015-11-11T00:00:00Z